• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性帕金森病的病理机制和治疗:过去、现在和未来。

Pathological mechanisms and treatment of sporadic Parkinson's disease: past, present, and future.

机构信息

Department of Neurology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

出版信息

J Neural Transm (Vienna). 2024 Jun;131(6):597-607. doi: 10.1007/s00702-024-02788-w. Epub 2024 Jun 12.

DOI:10.1007/s00702-024-02788-w
PMID:38864935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11192660/
Abstract

For a special issue, we review studies on the pathogenesis of nigral cell death and the treatment of sporadic Parkinson's disease (sPD) over the past few decades, with a focus on the studies performed by Prof. Mizuno and our group. Prof. Mizuno proposed the initial concept that mitochondrial function may be impaired in sPD. When working at Jichi Medical School, he found a decrease in complex I of the mitochondrial electron transfer complex in the substantia nigra of patients with Parkinson's disease (PD) and MPTP models. After moving to Juntendo University as a professor and chairman, he continued to study the mechanisms of cell death in the substantia nigra of patients with sPD. Under his supervision, I studied the relationships between PD and apoptosis, PD and iron involvement, mitochondrial dysfunction and apoptosis, and PD and neuroinflammation. Moving to Kitasato University, we focused on PD and the cytotoxicity of alpha synuclein (αSyn) as well as brain neuropathology. Eventually, I moved to Osaka University, where I continued working on PD and αSyn projects to promote therapeutic research. In this paper, we present the details of these studies in the following order: past, present, and future.

摘要

为了一期特刊,我们回顾了过去几十年中关于黑质细胞死亡的发病机制和散发性帕金森病(sPD)治疗的研究,重点介绍了 Mizuno 教授和我们小组的研究。Mizuno 教授提出了线粒体功能可能在 sPD 中受损的最初概念。在筑波大学医学科学研究所工作时,他发现帕金森病(PD)患者和 MPTP 模型的黑质中线粒体电子传递复合物 I 复合物减少。调到顺天堂大学担任教授和主席后,他继续研究 sPD 患者黑质细胞死亡的机制。在他的指导下,我研究了 PD 与细胞凋亡、PD 与铁参与、线粒体功能障碍与细胞凋亡以及 PD 与神经炎症之间的关系。搬到了北里大学,我们专注于 PD 和毒性α-突触核蛋白(αSyn)以及脑病理学。最终,我搬到了大阪大学,继续从事 PD 和αSyn 项目的研究,以促进治疗研究。在本文中,我们按照过去、现在和未来的顺序介绍了这些研究的详细信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d2/11192660/a79f82faa9ed/702_2024_2788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d2/11192660/a79f82faa9ed/702_2024_2788_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51d2/11192660/a79f82faa9ed/702_2024_2788_Fig1_HTML.jpg

相似文献

1
Pathological mechanisms and treatment of sporadic Parkinson's disease: past, present, and future.散发性帕金森病的病理机制和治疗:过去、现在和未来。
J Neural Transm (Vienna). 2024 Jun;131(6):597-607. doi: 10.1007/s00702-024-02788-w. Epub 2024 Jun 12.
2
Parkinson's disease and iron.帕金森病与铁。
J Neural Transm (Vienna). 2020 Feb;127(2):181-187. doi: 10.1007/s00702-020-02149-3. Epub 2020 Feb 5.
3
Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.α-突触核蛋白在黑质细胞内累积过程中线粒体复合物 IV 的可变表达。
Parkinsonism Relat Disord. 2021 Sep;90:57-61. doi: 10.1016/j.parkreldis.2021.08.001. Epub 2021 Aug 6.
4
Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.帕金森病患者接受和未接受深部脑刺激的神经病理学比较。
Mov Disord. 2017 Feb;32(2):274-277. doi: 10.1002/mds.26882. Epub 2016 Dec 2.
5
The Nigral Coup in Parkinson's Disease by α-Synuclein and Its Associated Rebels.帕金森病中α-突触核蛋白及其相关“叛乱者”引发的黑质打击。
Cells. 2021 Mar 9;10(3):598. doi: 10.3390/cells10030598.
6
Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.Ciita 在联合 rAAV-α-突触核蛋白和原纤维诱导的帕金森病大鼠模型中调节局部和全身免疫反应。
J Parkinsons Dis. 2024;14(4):693-711. doi: 10.3233/JPD-240062.
7
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.α-突触核蛋白致密聚集体的耗散与一种新的帕金森病模型中多巴胺能神经元功能障碍和死亡的挽救有关。
Acta Neuropathol. 2019 Oct;138(4):575-595. doi: 10.1007/s00401-019-02023-x. Epub 2019 May 31.
8
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
9
rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.rAAV2/7 载体介导的小鼠黑质中 alpha-突触核蛋白的过表达诱导蛋白聚集和进行性剂量依赖性神经退行性变。
Mol Neurodegener. 2013 Nov 25;8:44. doi: 10.1186/1750-1326-8-44.
10
[Pathological mechanisms of Parkinson's disease].[帕金森病的病理机制]
Brain Nerve. 2009 Apr;61(4):441-6.

引用本文的文献

1
From Tradition to Innovation: Acupuncture Therapies Targeting Ferroptosis in Neurological Disorders.从传统到创新:针对神经疾病中铁死亡的针灸疗法
Brain Behav. 2025 Sep;15(9):e70827. doi: 10.1002/brb3.70827.
2
Intercellular Adhesion Molecule 1 (ICAM-1): An Inflammatory Regulator with Potential Implications in Ferroptosis and Parkinson's Disease.细胞间黏附分子 1(ICAM-1):一种具有潜在意义的炎症调节剂,与铁死亡和帕金森病有关。
Cells. 2024 Sep 15;13(18):1554. doi: 10.3390/cells13181554.

本文引用的文献

1
Lysophagy protects against propagation of α-synuclein aggregation through ruptured lysosomal vesicles.溶酶体吞噬作用可防止破裂的溶酶体囊泡中α-突触核蛋白聚集物的传播。
Proc Natl Acad Sci U S A. 2024 Jan 2;121(1):e2312306120. doi: 10.1073/pnas.2312306120. Epub 2023 Dec 26.
2
Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.三磷酸肌醇与α-突触核蛋白相互作用,并引发其聚集和形成帕金森病相关纤维多态性。
Acta Neuropathol. 2023 May;145(5):573-595. doi: 10.1007/s00401-023-02555-3. Epub 2023 Mar 20.
3
Extracellular transportation of α-synuclein by HLA class II molecules.
HLA II类分子介导的α-突触核蛋白的细胞外转运
Biochem Biophys Res Commun. 2023 Feb 12;644:25-33. doi: 10.1016/j.bbrc.2022.12.082. Epub 2022 Dec 31.
4
Monoclonal Antibody Therapy in Parkinson's Disease - The End?帕金森病中的单克隆抗体疗法——终结?
N Engl J Med. 2022 Aug 4;387(5):466-467. doi: 10.1056/NEJMe2207681.
5
Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease.两步筛选法鉴定帕金森病α-突触核蛋白聚集抑制剂。
Sci Rep. 2022 Jan 10;12(1):351. doi: 10.1038/s41598-021-04131-9.
6
Recent Advances in the Development of Stem-Cell-Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease.近年来,基于干细胞的多巴胺能神经元移植疗法治疗帕金森病的研究进展。
Mov Disord. 2021 Aug;36(8):1772-1780. doi: 10.1002/mds.28628. Epub 2021 May 8.
7
Alternative mitochondrial quality control mediated by extracellular release.通过细胞外释放实现的替代性线粒体质量控制。
Autophagy. 2021 Oct;17(10):2962-2974. doi: 10.1080/15548627.2020.1848130. Epub 2020 Dec 10.
8
The secondary structural difference between Lewy body and glial cytoplasmic inclusion in autopsy brain with synchrotron FTIR micro-spectroscopy.利用同步辐射傅里叶变换红外光谱显微镜对尸检大脑中路易小体和胶质细胞胞质内含物进行二级结构差异分析。
Sci Rep. 2020 Nov 10;10(1):19423. doi: 10.1038/s41598-020-76565-6.
9
Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System.过岗龙津甘通过中枢神经系统 p38-TNF 信号减轻神经紊乱中的炎症。
Neurotherapeutics. 2021 Jan;18(1):460-473. doi: 10.1007/s13311-020-00948-w. Epub 2020 Oct 20.
10
Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.结构不同的α-突触核蛋白纤维可诱导出强烈的帕金森病病理。
Mov Disord. 2020 Feb;35(2):256-267. doi: 10.1002/mds.27887. Epub 2019 Oct 23.